WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009066315) SUSTAINED RELEASE COMPOSITIONS OF TRIMETAZIDINE AND PROCESS FOR PREPARATION THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/066315    International Application No.:    PCT/IN2008/000493
Publication Date: 28.05.2009 International Filing Date: 07.08.2008
IPC:
A61K 9/22 (2006.01), A61K 31/495 (2006.01), A61P 9/10 (2006.01)
Applicants: USV LIMITED [IN/IN]; B.S.D. Marg, Station Road, Govandi, Mumbai 400 088, Maharashtra (IN) (For All Designated States Except US).
HEGDE, Deepak, Anant [IN/IN]; (IN) (For US Only).
SHENOY, Sandhya, Rajendra [IN/IN]; (IN) (For US Only).
BHATT, Harish, Tulsidutt [IN/IN]; (IN) (For US Only).
OMRAY, Ashok [IN/IN]; (IN) (For US Only)
Inventors: HEGDE, Deepak, Anant; (IN).
SHENOY, Sandhya, Rajendra; (IN).
BHATT, Harish, Tulsidutt; (IN).
OMRAY, Ashok; (IN)
Priority Data:
1533/MUM/2007 08.08.2007 IN
Title (EN) SUSTAINED RELEASE COMPOSITIONS OF TRIMETAZIDINE AND PROCESS FOR PREPARATION THEREOF
(FR) COMPOSITIONS À LIBÉRATION PROLONGÉE DE TRIMÉTAZIDINE ET PROCÉDÉ DE PRÉPARATION
Abstract: front page image
(EN)Disclosed herein are sustained release pharmaceutical compositions comprising Trimetazidine or a pharmaceutically acceptable salt thereof and release modifying agents together with suitable pharmaceutically acceptable excipients. The sustained release pharmaceutical compositions of the present invention are characterized by the absence of cellulose and/or their derivatives as release modifying agents.
(FR)La présente invention porte sur des compositions pharmaceutiques à libération prolongée contenant de la trimétazidine ou un sel pharmaceutiquement acceptable de celle-ci et des agents modifiant la libération ainsi que des excipients pharmaceutiquement acceptables appropriés. Les compositions pharmaceutiques à libération prolongée selon la présente invention se caractérisent par l'absence de cellulose et/ou de dérivés de cellulose en tant qu'agents modifiant la libération.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)